a public good project by the
Synthesis
Company
of California

© 2026

Joan Levy | doi.page

0 works0 citations0 h-index

Joan Levy

Chordoma Foundation(US)

Publications by Year

Research Areas

Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Bone Tumor Diagnosis and Treatments, Bone Metabolism and Diseases, Cancer Genomics and Diagnostics

Most-Cited Works

→ Initial genome sequencing and analysis of multiple myeloma(2011)1,437 cited
→ Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy(2014)994 cited
→ Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models(2006)463 cited
→ Cbl Associates with Pyk2 and Src to Regulate Src Kinase Activity, αvβ3 Integrin-Mediated Signaling, Cell Adhesion, and Osteoclast Motility(2001)369 cited
→ c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption(1996)288 cited
→ The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system(1993)227 cited

→ Osteoclasts express high levels of pp60c-src in association with intracellular membranes.(1992)

222 cited

→ Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21.(1991)208 cited

→ Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin.(1994)182 cited

→ Tyrosine Phosphorylation and Translocation of the c-Cbl Protein after Activation of Tyrosine Kinase Signaling Pathways(1995)169 cited